You are here: Industry Insights > Pifzer

News List

Pfizer plans 41 price hikes for January fiercepharma
November 26, 2018
Pfizer, which became the center of a drug pricing controversy this summer featuring President Donald Trump, has decided it’s ready to raise prices in early 2019.
Moments matter in BMS and Pfizer's latest afib effort fiercepharma
November 22, 2018
Pfizer and Bristol-Myers Squibb are taking on atrial fibrillation again with a new awareness campaign. Called “Matter of Moments...
Pfizer pulls support for senator after 'hanging' comments fiercepharma
November 22, 2018
Amid a senate runoff in Mississippi, comments from Republican Sen. Cindy Hyde-Smith have led Pfizer to rebuke the senator and ask for a refund in campaign contributions.
Merck and Pfizer chalk up another fail for Bavencio pharmaphorum
November 21, 2018
Merck KGaA and Pfizer’s late entrant to the checkpoint inhibitor category has failed a phase III trial in ovarian cancer, denting their hopes of building momentum for the product.
Pfizer to resume price hiking in 2019; 41 drugs set to increase November 21, 2018
American pharma firm Pfizer has revealed plans to increase the prices of 41 medicines, the equivalent of 10% of its entire drug portfolio, as of 15 January, 2019.
Roche's Alecensa topples Pfizer's Xalkori in Asian patients with ALK+ advanced lung cancer pharmafile
November 01, 2018
Following up on the reveal of data concerning its immunotherapy Tecentriq in combination with chemotherapy in the treatment of non-small cell lung cancer, Roche unveiled a second wave of findings at the European ...